Akanda Corp. (AKAN) vs Cellyan Biotechnology Co., Ltd (HKPD)
A side-by-side comparison of Akanda Corp. and Cellyan Biotechnology Co., Ltd across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AKAN
Akanda Corp.
$1.89HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
HKPD
Cellyan Biotechnology Co., Ltd
$0.10HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — AKAN vs HKPD
growth of $100 · dividends reinvested · last 2yAKAN -98.0% (-85.9%/yr)HKPD -96.3% (-80.8%/yr)HKPD compounded faster over this window
AKAN HKPD
AKAN vs HKPD: by the numbers
- •HKPD is the larger company ($1M vs $61172 market cap).
- •Both run net losses; HKPD's is the smaller (-8.46% vs -17690.19% net margin).
Metrics side by side
Valuation
| Metric | AKAN | HKPD |
|---|---|---|
| P/B ratio | N/A | 0.12 |
Profitability
| Metric | AKAN | HKPD |
|---|---|---|
| Gross margin | -60.46% | 10.32% |
| Operating margin | -1930.99% | -7.41% |
| Net margin | -17690.19% | -8.46% |
| ROE | N/A | -11.85% |
| ROIC | -242.09% | -9.45% |
Growth (annualized)
| Metric | AKAN | HKPD |
|---|---|---|
| Revenue CAGR (5Y) | 162.75% | N/A |
Go deeper
Dig into the metrics
Akanda ROECellyan Biotechnology ROEAkanda operating marginCellyan Biotechnology operating marginAkanda revenue growthCellyan Biotechnology revenue growthAkanda free cash flowCellyan Biotechnology free cash flow
Akanda & Cellyan Biotechnology appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.